Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MVA Mosaic HIV vaccine - Janssen Vaccines and Prevention

Next Previous
Drug Profile

MVA Mosaic HIV vaccine - Janssen Vaccines and Prevention

Alternative Names: Modified Vaccinia Ankara Mosaic HIV vaccine - Janssen Vaccines and Prevention; Modified vaccinia ankara mosaic vaccine-Janssen Vaccines and Prevention; MVA HIV vaccine-Janssen Vaccines and Prevention; MVA mosaic-Janssen Vaccines and Prevention; MVA-Mosaic

Latest Information Update: 25 Jul 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Crucell Holland
  • Developer Beth Israel Deaconess Medical Center; Janssen Vaccines and Prevention B.V
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II HIV infections

Most Recent Events

  • 01 Mar 2022 Janssen Vaccines & Prevention B.V. completes a phase-I/II clinical trials in HIV infections (Prevention) in USA, Uganda, Thailand, South Africa, Rwanda (IM) (NCT02315703)
  • 29 Sep 2021 Phase-I/II development in HIV infections (Combination therapy, Prevention) is still ongoing Uganda, USA, Rwanda, South Africa, Thailand (IM) (NCT02315703)
  • 29 Sep 2021 No development reported - Phase-I/II for HIV infections (Combination therapy, Treatment-experienced) in Thailand (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top